Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - Midas Medici Group Holdings, Inc. | ex992.htm |
| EX-99.1 - EXHIBIT 99.1 - Midas Medici Group Holdings, Inc. | ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest reported): August 5, 2011
Midas Medici Group Holdings, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 000-52621 | 37-1532843 |
| (State or other jurisdiction of incorporation) | Commission file number | (IRS Employer Identification No.) |
445 Park Avenue, 20th Floor, New York, New York 10222
Registrant’s telephone number, including area code (212) 792-0920
Copies to:
Thomas Rose, Esq.
Marcelle S. Balcombe, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32 nd Floor
New York, New York 10006
Phone: (212) 930-9700
Fax: (212) 930-9725
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
/_/ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
/_/ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
/_/ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
/_/ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01
|
Regulation FD Disclosure.
|
On August 5, 2011 and August 8, 2011, Midas Medici Group Holdings, Inc. issued press releases disclosing the completion of the acquisition of a 60% interest in Cimcorp, Inc. The press releases are being furnished as Exhibit 99.1 and Exhibit 99.2 to this current report on Form 8-K.
The information in this Item 7.01 of this current report on Form 8-K, together with the information in Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Such information shall not be deemed incorporated by reference into any registration statement or other document filed with the SEC.
|
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
| Exhibit Number | Description | |
|
99.1*
|
Press Release issued on August 5, 2011
|
|
| 99.2* | Press Release issued on August 8, 2011 |
* Filed herewith
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Midas Medici Group Holdings, Inc.
|
|||
|
Date: August 10, 2011
|
By:
|
/s/ Nana Baffour | |
|
Nana Baffour
|
|||
|
Chief Executive Officer
|
|||